Quick Facts

Challenge

The spin off for the new company left limited US presence and limited time to create the new name, brand, and prepare for a drug launch.

Solution

The project kicked-off with a global strategy and brand training session with the newly created team, we identified key words, positioning for mission, vision, and values and brainstormed creative names. After over 300 names, the client chose Zionexa to represent a keen focus on innovation and collaborative approaches in developing and commercializing the next generation of radiopharmaceuticals. The logo and website were then designed and launched to reflect this brand vision and provide a foundation for the growth of the company and the launch of new products in molecular imaging.

Zionexa Website
Zionexa Mobile

Impact

Creating and nurturing brand appeal markets in the United States and Europe, through building successful brand identity and effective digital experiences to prepare for commercial drug launch. The brand was sold to GE Healthcare in 2021 with plans to develop and bring to market Zionexa’s pipeline biomarkers, as well as the recently FDA-approved PET imaging agent, Cerianna™ (fluoroestradiol F-18), which is used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer.

Let's make something great together

Ready to optimize your marketing and see better results?

TOP